Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
4.
Rev Clin Esp (Barc) ; 219(6): 342-343, 2019.
Article de Anglais, Espagnol | MEDLINE | ID: mdl-30591193
5.
Rev Alerg Mex ; 53(1): 34-41, 2006.
Article de Espagnol | MEDLINE | ID: mdl-16634360

RÉSUMÉ

Hereditary angioedema is a congenital disorder with recurrent attacks of localized swelling of submucosal and subcutaneous tissue, or both caused by a deficiency of the plasma protein C1 inhibitor. It is caused by heterozygous defects in the C1 inhibitor gene located on chromosome 11q, and it has an autosomal dominant inheritance pattern. This disease afflicts 1 in 10,000 to 1 in 150,000 persons. Hereditary angioedema has been reported in all races, and no sex predominance has been found. Skin and visceral organs may be involved by the typically massive local edema. The most commonly involved viscera are the respiratory and gastrointestinal systems, and it can affect the upper airways resulting in severe life-threatening symptoms, including the risk of asphyxiation. There are three types of hereditary angioedema, which difference lies in the inheritance pattern and in the C1 esterase inhibitor and C4 concentrations. The treatment is complicated and it should be treated with intravenous purified C1 inhibitor concentrate; corticosteroids, antihistamines and epinephrine can be useful adjuncts but they are not effective. We report a patient with hereditary angioedema type 1 and make a review of the medical literature.


Sujet(s)
Angioedème/génétique , Protéines inhibitrices de la fraction C1 du complément/déficit , Serpines/déficit , Adulte , Angioedème/classification , Angioedème/traitement médicamenteux , Angioedème/épidémiologie , Angioedème/physiopathologie , Angioedème/thérapie , Bradykinine/physiologie , Association thérapeutique , Protéines inhibitrices de la fraction C1 du complément/génétique , Protéines inhibitrices de la fraction C1 du complément/usage thérapeutique , C1 Inhibiteur , Complément C4/déficit , Danazol/usage thérapeutique , Association de médicaments , Femelle , Gènes dominants , Humains , Incidence , Serpines/génétique , Serpines/usage thérapeutique
6.
Am J Hematol ; 68(2): 69-74, 2001 Oct.
Article de Anglais | MEDLINE | ID: mdl-11559944

RÉSUMÉ

To evaluate the usefulness of flow cytometric detection of intracellular antigens (Ags) in establishing proper lineage affiliation and its contribution to the diagnosis of acute leukemia, we studied 100 consecutive patients in whom acute leukemia was diagnosed between January 1997 and July 1998. Immunological classification was assessed using a three-line panel of monoclonal antibodies for phenotypic characterization of leukemic blast cells as proposed at the First Latin American Consensus Conference for Flow Cytometric Immunophenotyping of Leukemia. We found 74 cases of B-cell lineage acute lymphoblastic leukemia (ALL), seven cases of T-cell ALL, and 19 cases of acute myeloid leukemia (AML). In this study cytoplasmic (cy) CD79a, cyCD22, cyCD3, and cyMPO were highly sensitive, specific B, T, and myeloid markers that were expressed in virtually all cases of B and T cell ALL and in all subtypes of AML. Applied in combination with immunophenotyping this knowledge led to improvement in diagnostic precision and refinement of immunological classification, ensuring the selection of the most appropriate therapy for the patients studied. In conclusion, intracellular Ags detection was of utmost importance in establishing correct lineage affiliation in cases lacking expression of B, T, or myeloid surface Ags or disclosing equivocal or ambiguous immunophenotypic features and in identifying biphenotypic acute leukemia. In combination with FAB morphology and immunophenotyping, we were able to reliably classify all patients with acute leukemia in this study.


Sujet(s)
Antigènes néoplasiques/analyse , Antigènes de surface/analyse , Marqueurs biologiques tumoraux/analyse , Cytoplasme/immunologie , Leucémies/diagnostic , Maladie aigüe , Antigènes/analyse , Marqueurs biologiques tumoraux/immunologie , Lymphome de Burkitt/classification , Lymphome de Burkitt/diagnostic , Lymphome de Burkitt/anatomopathologie , Lignage cellulaire/immunologie , Enfant , Diagnostic différentiel , Cytométrie en flux , Humains , Immunophénotypage , Leucémies/classification , Leucémies/anatomopathologie , Leucémie myéloïde/classification , Leucémie myéloïde/diagnostic , Leucémie myéloïde/anatomopathologie , Leucémie-lymphome à cellules T de l'adulte/classification , Leucémie-lymphome à cellules T de l'adulte/diagnostic , Leucémie-lymphome à cellules T de l'adulte/anatomopathologie
7.
Sangre (Barc) ; 44(3): 188-94, 1999 Jun.
Article de Espagnol | MEDLINE | ID: mdl-10481579

RÉSUMÉ

PURPOSE: To analyse the immunophenotype of leukaemic cells in a group of children diagnosed of lymphoblastic leukaemia in order to assess the frequency of the different immunologic subtypes. PATIENTS AND METHODS: In the period comprised between APR 1987 and MAR 1995, 402 Mexican children were studied in a prospective way. Conventional immunological markers were used, either associated to or specific for B, T, myelo-monocytic or megakaryocytic-platelet cell populations. RESULTS: Five major immunologic subtypes were disclosed, showing a series of specific surface markers: null-ALL, 5%; early pre-B, 7.5%; common, 74.6%; B-cell, 3.5%, and T-cell, 9.4%. A net predominance of B-cell precursor CD10- ALL was found in children under one year of age, and of CD10+ B-cells beyond that age. Although there was only slight predominance of male sex, the prevalence of B and TALL in males was not confirmed. CONCLUSIONS: These results show that the incidence of the different immunologic subtypes of lymphoblastic leukaemias and their distribution according to age and sex are closely similar to those reported among Caucasians in other parts of the world.


Sujet(s)
Antigènes CD/analyse , Antigènes néoplasiques/analyse , Cellules souches tumorales/immunologie , Leucémie-lymphome lymphoblastique à précurseurs B et T/anatomopathologie , Adolescent , Lymphome de Burkitt/épidémiologie , Lymphome de Burkitt/immunologie , Lymphome de Burkitt/anatomopathologie , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Immunophénotypage , Incidence , Nourrisson , Leucémie-lymphome à cellules T de l'adulte/épidémiologie , Leucémie-lymphome à cellules T de l'adulte/immunologie , Leucémie-lymphome à cellules T de l'adulte/anatomopathologie , Mâle , Mexique/épidémiologie , Leucémie-lymphome lymphoblastique à précurseurs B/épidémiologie , Leucémie-lymphome lymphoblastique à précurseurs B/immunologie , Leucémie-lymphome lymphoblastique à précurseurs B/anatomopathologie , Leucémie-lymphome lymphoblastique à précurseurs B et T/classification , Leucémie-lymphome lymphoblastique à précurseurs B et T/épidémiologie , Leucémie-lymphome lymphoblastique à précurseurs B et T/immunologie , Études prospectives
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...